Approval · Notice of Compliance 26674 · 2021
MONOFERRIC: Notice of Compliance 26674
Issued September 17, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26674
- Date
- September 17, 2021
- Company
- Pharmacosmos AHolbaek, Denmark
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the Product Monograph and update to the common name.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MONOFERRIC | Not yet assigned | — |
Medicinal ingredients
- FERRIC DERISOMALTOSE 100 MG per ML